Wells Fargo’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-40
Closed 6595
2016
Q1
$0 Hold
40
﹤0.01% 6651
2015
Q4
$0 Hold
40
﹤0.01% 6617
2015
Q3
$0 Sell
40
-800
-95% -$935 ﹤0.01% 6676
2015
Q2
$1K Buy
840
+800
+2,000% +$1.2K ﹤0.01% 6297
2015
Q1
$0 Hold
40
﹤0.01% 6553
2014
Q4
$0 Hold
40
﹤0.01% 6592
2014
Q3
$0 Hold
40
﹤0.01% 6506
2014
Q2
$0 Hold
40
﹤0.01% 6445
2014
Q1
$0 Sell
40
-20
-33% -$103 ﹤0.01% 6254
2013
Q4
$0 Hold
60
﹤0.01% 6106
2013
Q3
$0 Sell
60
-3,000
-98% -$14.1K ﹤0.01% 6003
2013
Q2
$13K Buy
+3,060
New +$13.9K ﹤0.01% 4999

Wells Fargo's ALXA Position: Q2 2016 in Review

Wells Fargo sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 40 shares.

Wells Fargo first reported a position in ALXA in Q2 2013 and held it in 12 quarters. The position peaked at $13K in Q2 2013. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

  • Wells Fargo reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Wells Fargo sold 40 Alexza Pharmaceuticals Inc shares in Q2 2016.
  • Wells Fargo first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
  • Wells Fargo's Alexza Pharmaceuticals Inc position peaked at $13K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on Wells Fargo's 13F filing for Q2 2016, filed 11 Aug 2016.